Faiza Khan
Physician Assistant · Shelby Township, MINPI 1417515800
Payments from drug & device makers
Across 235 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$885
- Medtronic$384
- Abbott$289
- Xeris Pharmaceuticals, Inc.$252
- Lilly USA, LLC$245
- AbbVie$230
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,239100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 60 | $885 |
| Medtronic | 17 | $384 |
| Abbott | 19 | $289 |
| Xeris Pharmaceuticals, Inc. | 13 | $252 |
| Lilly USA, LLC | 12 | $245 |
| AbbVie | 11 | $230 |
| Sanofi-aventis U.S. LLC | 11 | $206 |
| Boehringer Ingelheim | 11 | $199 |
| Amgen | 9 | $164 |
| AstraZeneca(2 entities) | 7 | $124 |
| Recordati_rare_diseases_inc. | 5 | $123 |
| Mannkind Corporation | 7 | $117 |
| Amneal Pharmaceuticals LLC | 6 | $110 |
| Corcept Therapeutics | 5 | $108 |
| BD | 5 | $99 |
| Nevro Corp. | 3 | $85 |
| Halozyme Inc | 4 | $79 |
| Antares Pharma, Inc. | 3 | $66 |
| IBSA Pharma Inc. | 4 | $64 |
| Amryt Pharma Holdings Ltd | 4 | $56 |
| Dexcom, Inc. | 2 | $39 |
| Clarus Therapeutics Inc. | 2 | $36 |
| Embecta Corp. | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $31 |
| EUSA Pharma (US) LLC | 1 | $26 |
| Insulet Corporation | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Sequel Med Tech, LLC | 1 | $19 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Alvogen Inc | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Bayer | 1 | $16 |
| Lifescan, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,239 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 231 | $386,919 |
| JardianceEmpagliflozin | 207 | $266,132 |
| MounjaroTirzepatide | 136 | $222,845 |
| TrulicityDulaglutide | 52 | $110,974 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 43 | $48,602 |
| JanuviaSitagliptin Phosphate | 31 | $42,186 |
| FarxigaDapagliflozin Propanediol | 46 | $32,117 |
| Tresiba Flextouch U-100Insulin Degludec | 26 | $20,908 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 16 | $19,637 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $16,049 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 12 | $12,182 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 70 | $11,276 |
| Humalog Kwikpen U-100Insulin Lispro | 33 | $10,501 |
| Novolog FlexpenInsulin Aspart | 26 | $8,434 |
| NovologInsulin Aspart | 11 | $4,631 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $885 | $391,550242 claims |
| Lilly USA, LLCMounjaro, Trulicity | $245 | $333,819188 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $199 | $314,734250 claims |
| AstraZenecaFarxiga | $124 | $32,11746 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $206 | $16,98022 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $110 | $2,462191 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Shelby Township
- Labrene TangalosShelby Township$14K
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.